Nu Skin (NYSE:NUS) Hit With Buy Rating From Jefferies, Analysts Expect $98 Stock Price

June 14, 2018 - By Ash Ash

Nu Skin Enterprises, Inc. (NYSE:NUS) Logo

Investors sentiment increased to 1.42 in 2018 Q1. Its up 0.26, from 1.16 in 2017Q4. It improved, as 19 investors sold Nu Skin Enterprises, Inc. shares while 73 reduced holdings. 48 funds opened positions while 83 raised stakes. 39.34 million shares or 4.86% more from 37.52 million shares in 2017Q4 were reported.

Signaturefd Ltd Company stated it has 240 shares. Gemmer Asset Mgmt Limited Company reported 0% stake. Commonwealth Of Pennsylvania Pub School Empls Retrmt Sys reported 0.01% stake. Robeco Institutional Asset Mngmt Bv owns 83,056 shares. 324,283 were reported by Mackay Shields. Manufacturers Life Insurance The owns 79,258 shares. Public Employees Retirement Sys Of Ohio owns 0.02% invested in Nu Skin Enterprises, Inc. (NYSE:NUS) for 51,520 shares. Suntrust Banks stated it has 0% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS). Wealthcare Capital Mngmt Lc owns 100 shares or 0% of their US portfolio. Moreover, State Of Alaska Department Of Revenue has 0.01% invested in Nu Skin Enterprises, Inc. (NYSE:NUS). Oakbrook Invests reported 4,190 shares stake. Amundi Pioneer Asset invested in 1,370 shares or 0% of the stock. 11,460 are held by Pub Employees Retirement Association Of Colorado. Washington Tru National Bank accumulated 1,514 shares. The New York-based Citigroup has invested 0% in Nu Skin Enterprises, Inc. (NYSE:NUS).

Since January 19, 2018, it had 0 insider purchases, and 12 insider sales for $119.00 million activity. 724 shares were sold by Lawrence Mark H, worth $52,751 on Thursday, March 8. $1.60 million worth of Nu Skin Enterprises, Inc. (NYSE:NUS) was sold by LUND STEVEN on Friday, January 19. The insider Ping An ZQ China Growth Opportunity Ltd sold 1.54 million shares worth $107.49 million. OFFEN NEIL H sold 7,000 shares worth $571,620. Thomas Pisano R. also sold $1.08 million worth of Nu Skin Enterprises, Inc. (NYSE:NUS) on Wednesday, March 7.

Why Has Jefferies Given Nu Skin (NYSE:NUS) a $98 Price Target

The research firm Jefferies has today has started coverage on Nu Skin (NYSE:NUS) shares, with a Buy rating, while giving it the TP at $98.

Nu Skin Enterprises, Inc. (NYSE:NUS) Ratings Coverage

Among 3 analysts covering Nu Skin (NYSE:NUS), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Nu Skin has $82 highest and $57.0 lowest target. $72’s average target is -13.84% below currents $83.57 stock price. Nu Skin had 5 analyst reports since January 23, 2018 according to SRatingsIntel. The company was downgraded on Friday, April 13 by Deutsche Bank. As per Friday, February 16, the company rating was maintained by Deutsche Bank. On Thursday, February 15 the stock rating was maintained by Stifel Nicolaus with “Sell”. Citigroup maintained it with “Buy” rating and $82 target in Monday, April 30 report.

The stock increased 1.94% or $1.59 during the last trading session, reaching $83.57. About 307,324 shares traded. Nu Skin Enterprises, Inc. (NYSE:NUS) has risen 45.84% since June 14, 2017 and is uptrending. It has outperformed by 33.27% the S&P500.

Analysts await Nu Skin Enterprises, Inc. (NYSE:NUS) to report earnings on August, 1. They expect $0.89 earnings per share, up 15.58 % or $0.12 from last year’s $0.77 per share. NUS’s profit will be $49.49M for 23.47 P/E if the $0.89 EPS becomes a reality. After $0.64 actual earnings per share reported by Nu Skin Enterprises, Inc. for the previous quarter, Wall Street now forecasts 39.06 % EPS growth.

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. The company has market cap of $4.65 billion. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC Transformation anti-aging skin care systems; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. It has a 35.41 P/E ratio. The firm also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.

More important recent Nu Skin Enterprises, Inc. (NYSE:NUS) news were published by: Seekingalpha.com which released: “Featured Stocks In May’s Dividend Growth Model Portfolio” on June 07, 2018, also Benzinga.com published article titled: “Jefferies Offers 4 Reasons To Like Nu Skin Enterprises”, Benzinga.com published: “Benzinga’s Top Upgrades, Downgrades For June 14, 2018” on June 14, 2018. More interesting news about Nu Skin Enterprises, Inc. (NYSE:NUS) was released by: 247Wallst.com and their article: “Top Analyst Upgrades and Downgrades: Capital One, Hewlett Packard Enterprises, Kohl’s, Roku, Spotify, Steel …” with publication date: June 14, 2018.

Nu Skin Enterprises, Inc. (NYSE:NUS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: